E-DRUG: Two international summer courses in the heart of the Netherlands
------------------------------------------------------
This summer, the Division of Pharmacoepidemiology and Pharmacotherapy at Utrecht University, the Netherlands, offers you two challenging international summer courses in Pharmacoepidemiology & Drug Safety and Pharmaceutical Policy Analysis (in collaboration with WHO). Both courses will cover the key issues in each field and focus on the most important research methods used. All course teachers have extensive expertise in their field. You can apply for either one of the courses or for both (reduced fee). In addition, there is a cultural and social programme arranged for you to make sure that you experience the best of Utrecht. We look forward to welcoming you in Utrecht!
For more information, see www.utrechtsummerschool.nl
M8 Pharmacoepidemiology & Drug Safety (29 June - 3 July 2009)
--------------------------------------------------
With the prospect that innovative drug therapies will be introduced in the coming years, society demands new approaches and concepts for comparative risk/benefit evaluation. These evaluations are carried out once these therapies have been used widely in daily practice. Assessment of safety and risk management of different drug therapies is done in the framework of observational epidemiological studies (proof of "safety", proof of "effectiveness"). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drugs "efficacy".
The course will cover key issues in pharmacoepidemiologic and drug safety research. Special topics include databases and molecular pharmacoepidemiology. All course teachers have extended expertise in the design and conduct of pharmacoepidemiologic studies.
WHAT TO EXPECT?
You will experience an intensive programme covering the following topics:
- Study Design and Methods
- Confounding and other biases
- Methods in drug safety research
- Drug Safety and Risk Management
- Overview of Pharmacoepidemiological databases
- Molecular Pharmacoepidemiology
- Drug utilization research
- Synthesis, case studies & public health
COURSE DIRECTOR AND LECTURERS
Prof. Samy Suissa, Prof. Bert Leufkens, Prof. Ton de Boer, Prof. Toine Egberts, Dr. Olaf Klungel (course director), Dr. Tjeerd van Staa.
TARGET GROUP
Postgraduates, clinicians and professionals within governments, industry, universities with a basic knowledge of epidemiology and an interest in pharmacoepidemiology and risk/benefit evaluation of drug therapies.
M7 International Pharmaceutical Policy Analysis (6-10 July 2009)
--------------------------------------------------------------
Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, from a global perspective, the reality is that two billion people do not have access to essential medicines. The inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.
This course will cover these issues from a scientific, regulatory, public health and international policy perspective. As a collaborator on this course, WHO will provide faculty for several of the sessions.
WHAT TO EXPECT?
You will experience an intensive programme covering the following topics:
- New Medicines Policy - methods for evaluating policy
- Methods in pharmaceutical policy analysis
- Pharmacoepidemiology contribution to pharmaceutical policy analysis
- Drug usage, adherence to therapy and patient needs
- Regulatory issues and challenges
- Access, affordability and reimbursement systems
- Ethics and equity
- Current challenges in Drug Innovation
- Synthesis, case studies & public health
COURSE DIRECTOR
Prof. Bert Leufkens, Dr. Richard Laing (WHO) and Dr. Aukje Mantel
TARGET GROUP
(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge in public health/medicine and pharmacoepidemiology who have an interest in the policy aspects of pharmaceuticals.
General information
FEE PER COURSE
€ 900 Course + course materials + lunches + course dinner (excludes housing)
€ 1075 Course + course materials + lunches + course dinner (includes housing)
COMBINATION COURSE
These courses can be combined; combination fee: € 1400,- excluding housing
INFORMATION AND REGISTRATION
Deadline for registration is 31 May 2009.
Course M8: see also www.utrechtsummerschool.nl/index.php?type=courses&code=M8
or mail O.H.Klungel@uu.nl.
Course M7: see also www.utrechtsummerschool.nl/index.php?type=courses&code=M7
or mail A.K.Mantel@uu.nl